Overview

Pentoxifylline Therapy in Biliary Atresia

Status:
Recruiting
Trial end date:
2022-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether pentoxifylline reduces liver damage in infants with biliary atresia.
Phase:
Phase 2
Details
Lead Sponsor:
Baylor College of Medicine
Collaborator:
Texas Children's Hospital
Treatments:
Bilirubin
Pentoxifylline